nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Imiquimod—skin cancer	0.216	0.292	CbGbCtD
Tinidazole—CYP3A4—Temozolomide—skin cancer	0.216	0.292	CbGbCtD
Tinidazole—CYP3A4—Vismodegib—skin cancer	0.15	0.202	CbGbCtD
Tinidazole—CYP3A4—Vemurafenib—skin cancer	0.118	0.16	CbGbCtD
Tinidazole—CYP3A4—Docetaxel—skin cancer	0.0406	0.0548	CbGbCtD
Tinidazole—Malaise—Imiquimod—skin cancer	0.00104	0.00401	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00103	0.00399	CcSEcCtD
Tinidazole—Neutropenia—Dactinomycin—skin cancer	0.00103	0.00395	CcSEcCtD
Tinidazole—Stomatitis—Bleomycin—skin cancer	0.00102	0.00394	CcSEcCtD
Tinidazole—Palpitations—Imiquimod—skin cancer	0.00102	0.00393	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00101	0.00388	CcSEcCtD
Tinidazole—Candida infection—Docetaxel—skin cancer	0.001	0.00387	CcSEcCtD
Tinidazole—Convulsion—Imiquimod—skin cancer	0.000999	0.00385	CcSEcCtD
Tinidazole—Ataxia—Fluorouracil—skin cancer	0.000994	0.00383	CcSEcCtD
Tinidazole—Myalgia—Imiquimod—skin cancer	0.000982	0.00379	CcSEcCtD
Tinidazole—Arthralgia—Imiquimod—skin cancer	0.000982	0.00379	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000975	0.00376	CcSEcCtD
Tinidazole—Discomfort—Imiquimod—skin cancer	0.00097	0.00374	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00097	0.00374	CcSEcCtD
Tinidazole—Decreased appetite—Vemurafenib—skin cancer	0.00096	0.0037	CcSEcCtD
Tinidazole—Stomatitis—Dactinomycin—skin cancer	0.000953	0.00368	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000953	0.00367	CcSEcCtD
Tinidazole—Fatigue—Vemurafenib—skin cancer	0.000952	0.00367	CcSEcCtD
Tinidazole—Constipation—Vemurafenib—skin cancer	0.000944	0.00364	CcSEcCtD
Tinidazole—Hypoaesthesia—Bleomycin—skin cancer	0.000937	0.00361	CcSEcCtD
Tinidazole—Dysuria—Temozolomide—skin cancer	0.000928	0.00358	CcSEcCtD
Tinidazole—Neutropenia—Temozolomide—skin cancer	0.000928	0.00358	CcSEcCtD
Tinidazole—Nervous system disorder—Imiquimod—skin cancer	0.000923	0.00356	CcSEcCtD
Tinidazole—Skin disorder—Imiquimod—skin cancer	0.000914	0.00353	CcSEcCtD
Tinidazole—Hyperhidrosis—Imiquimod—skin cancer	0.00091	0.00351	CcSEcCtD
Tinidazole—Anorexia—Imiquimod—skin cancer	0.000897	0.00346	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000877	0.00338	CcSEcCtD
Tinidazole—Flushing—Bleomycin—skin cancer	0.000874	0.00337	CcSEcCtD
Tinidazole—Body temperature increased—Vemurafenib—skin cancer	0.000873	0.00336	CcSEcCtD
Tinidazole—Pharyngitis—Dactinomycin—skin cancer	0.000871	0.00336	CcSEcCtD
Tinidazole—Neuropathy peripheral—Temozolomide—skin cancer	0.000867	0.00334	CcSEcCtD
Tinidazole—Stomatitis—Temozolomide—skin cancer	0.000862	0.00332	CcSEcCtD
Tinidazole—Urinary tract infection—Temozolomide—skin cancer	0.00086	0.00332	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000858	0.00331	CcSEcCtD
Tinidazole—Insomnia—Imiquimod—skin cancer	0.000851	0.00328	CcSEcCtD
Tinidazole—Paraesthesia—Imiquimod—skin cancer	0.000845	0.00326	CcSEcCtD
Tinidazole—Dyspnoea—Imiquimod—skin cancer	0.000839	0.00324	CcSEcCtD
Tinidazole—Somnolence—Imiquimod—skin cancer	0.000837	0.00323	CcSEcCtD
Tinidazole—Erythema multiforme—Dactinomycin—skin cancer	0.00083	0.0032	CcSEcCtD
Tinidazole—Dyspepsia—Imiquimod—skin cancer	0.000829	0.0032	CcSEcCtD
Tinidazole—Decreased appetite—Imiquimod—skin cancer	0.000818	0.00316	CcSEcCtD
Tinidazole—Flushing—Dactinomycin—skin cancer	0.000815	0.00314	CcSEcCtD
Tinidazole—Hypersensitivity—Vemurafenib—skin cancer	0.000813	0.00314	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Imiquimod—skin cancer	0.000813	0.00313	CcSEcCtD
Tinidazole—Fatigue—Imiquimod—skin cancer	0.000812	0.00313	CcSEcCtD
Tinidazole—Neuropathy peripheral—Fluorouracil—skin cancer	0.000799	0.00308	CcSEcCtD
Tinidazole—Stomatitis—Fluorouracil—skin cancer	0.000794	0.00306	CcSEcCtD
Tinidazole—Urinary tract infection—Fluorouracil—skin cancer	0.000792	0.00305	CcSEcCtD
Tinidazole—Asthenia—Vemurafenib—skin cancer	0.000792	0.00305	CcSEcCtD
Tinidazole—Hypoaesthesia—Temozolomide—skin cancer	0.00079	0.00305	CcSEcCtD
Tinidazole—Pharyngitis—Temozolomide—skin cancer	0.000788	0.00304	CcSEcCtD
Tinidazole—Urinary tract disorder—Temozolomide—skin cancer	0.000784	0.00302	CcSEcCtD
Tinidazole—Pruritus—Vemurafenib—skin cancer	0.000781	0.00301	CcSEcCtD
Tinidazole—Urethral disorder—Temozolomide—skin cancer	0.000778	0.003	CcSEcCtD
Tinidazole—Feeling abnormal—Imiquimod—skin cancer	0.000776	0.00299	CcSEcCtD
Tinidazole—Gastrointestinal pain—Imiquimod—skin cancer	0.00077	0.00297	CcSEcCtD
Tinidazole—Ill-defined disorder—Bleomycin—skin cancer	0.00076	0.00293	CcSEcCtD
Tinidazole—Diarrhoea—Vemurafenib—skin cancer	0.000755	0.00291	CcSEcCtD
Tinidazole—Erythema multiforme—Temozolomide—skin cancer	0.000751	0.00289	CcSEcCtD
Tinidazole—Urticaria—Imiquimod—skin cancer	0.000748	0.00288	CcSEcCtD
Tinidazole—Abdominal pain—Imiquimod—skin cancer	0.000744	0.00287	CcSEcCtD
Tinidazole—Body temperature increased—Imiquimod—skin cancer	0.000744	0.00287	CcSEcCtD
Tinidazole—Malaise—Bleomycin—skin cancer	0.000739	0.00285	CcSEcCtD
Tinidazole—Flushing—Temozolomide—skin cancer	0.000737	0.00284	CcSEcCtD
Tinidazole—Leukopenia—Bleomycin—skin cancer	0.000733	0.00283	CcSEcCtD
Tinidazole—Dizziness—Vemurafenib—skin cancer	0.00073	0.00281	CcSEcCtD
Tinidazole—Hypoaesthesia—Fluorouracil—skin cancer	0.000728	0.00281	CcSEcCtD
Tinidazole—Pharyngitis—Fluorouracil—skin cancer	0.000726	0.0028	CcSEcCtD
Tinidazole—Angiopathy—Temozolomide—skin cancer	0.00072	0.00278	CcSEcCtD
Tinidazole—Ataxia—Docetaxel—skin cancer	0.000718	0.00277	CcSEcCtD
Tinidazole—Immune system disorder—Temozolomide—skin cancer	0.000717	0.00277	CcSEcCtD
Tinidazole—Ill-defined disorder—Dactinomycin—skin cancer	0.000709	0.00273	CcSEcCtD
Tinidazole—Vomiting—Vemurafenib—skin cancer	0.000702	0.00271	CcSEcCtD
Tinidazole—Myalgia—Bleomycin—skin cancer	0.000698	0.00269	CcSEcCtD
Tinidazole—Rash—Vemurafenib—skin cancer	0.000696	0.00268	CcSEcCtD
Tinidazole—Dermatitis—Vemurafenib—skin cancer	0.000695	0.00268	CcSEcCtD
Tinidazole—Hypersensitivity—Imiquimod—skin cancer	0.000694	0.00267	CcSEcCtD
Tinidazole—Headache—Vemurafenib—skin cancer	0.000692	0.00267	CcSEcCtD
Tinidazole—Malnutrition—Temozolomide—skin cancer	0.000691	0.00267	CcSEcCtD
Tinidazole—Discomfort—Bleomycin—skin cancer	0.000689	0.00266	CcSEcCtD
Tinidazole—Malaise—Dactinomycin—skin cancer	0.000689	0.00266	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000687	0.00265	CcSEcCtD
Tinidazole—Cramp muscle—Docetaxel—skin cancer	0.000687	0.00265	CcSEcCtD
Tinidazole—Leukopenia—Dactinomycin—skin cancer	0.000684	0.00264	CcSEcCtD
Tinidazole—Dysgeusia—Temozolomide—skin cancer	0.000677	0.00261	CcSEcCtD
Tinidazole—Asthenia—Imiquimod—skin cancer	0.000675	0.0026	CcSEcCtD
Tinidazole—Confusional state—Bleomycin—skin cancer	0.000674	0.0026	CcSEcCtD
Tinidazole—Pruritus—Imiquimod—skin cancer	0.000666	0.00257	CcSEcCtD
Tinidazole—Nausea—Vemurafenib—skin cancer	0.000656	0.00253	CcSEcCtD
Tinidazole—Thrombocytopenia—Bleomycin—skin cancer	0.000655	0.00252	CcSEcCtD
Tinidazole—Myalgia—Dactinomycin—skin cancer	0.000651	0.00251	CcSEcCtD
Tinidazole—Bronchospasm—Docetaxel—skin cancer	0.000649	0.0025	CcSEcCtD
Tinidazole—Diarrhoea—Imiquimod—skin cancer	0.000644	0.00248	CcSEcCtD
Tinidazole—Discomfort—Dactinomycin—skin cancer	0.000643	0.00248	CcSEcCtD
Tinidazole—Ill-defined disorder—Temozolomide—skin cancer	0.000641	0.00247	CcSEcCtD
Tinidazole—Anorexia—Bleomycin—skin cancer	0.000637	0.00246	CcSEcCtD
Tinidazole—Angioedema—Temozolomide—skin cancer	0.000632	0.00244	CcSEcCtD
Tinidazole—Malaise—Temozolomide—skin cancer	0.000623	0.0024	CcSEcCtD
Tinidazole—Dizziness—Imiquimod—skin cancer	0.000622	0.0024	CcSEcCtD
Tinidazole—Vertigo—Temozolomide—skin cancer	0.000621	0.00239	CcSEcCtD
Tinidazole—Leukopenia—Temozolomide—skin cancer	0.000619	0.00239	CcSEcCtD
Tinidazole—Neutropenia—Docetaxel—skin cancer	0.000617	0.00238	CcSEcCtD
Tinidazole—Palpitations—Temozolomide—skin cancer	0.000611	0.00236	CcSEcCtD
Tinidazole—Thrombocytopenia—Dactinomycin—skin cancer	0.000611	0.00235	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000609	0.00235	CcSEcCtD
Tinidazole—Paraesthesia—Bleomycin—skin cancer	0.000601	0.00232	CcSEcCtD
Tinidazole—Convulsion—Temozolomide—skin cancer	0.000599	0.00231	CcSEcCtD
Tinidazole—Vomiting—Imiquimod—skin cancer	0.000599	0.00231	CcSEcCtD
Tinidazole—Dyspnoea—Bleomycin—skin cancer	0.000596	0.0023	CcSEcCtD
Tinidazole—Anorexia—Dactinomycin—skin cancer	0.000595	0.00229	CcSEcCtD
Tinidazole—Rash—Imiquimod—skin cancer	0.000594	0.00229	CcSEcCtD
Tinidazole—Dermatitis—Imiquimod—skin cancer	0.000593	0.00229	CcSEcCtD
Tinidazole—Headache—Imiquimod—skin cancer	0.00059	0.00227	CcSEcCtD
Tinidazole—Arthralgia—Temozolomide—skin cancer	0.000588	0.00227	CcSEcCtD
Tinidazole—Myalgia—Temozolomide—skin cancer	0.000588	0.00227	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000584	0.00225	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000583	0.00225	CcSEcCtD
Tinidazole—Discomfort—Temozolomide—skin cancer	0.000581	0.00224	CcSEcCtD
Tinidazole—Decreased appetite—Bleomycin—skin cancer	0.000581	0.00224	CcSEcCtD
Tinidazole—Neuropathy peripheral—Docetaxel—skin cancer	0.000577	0.00222	CcSEcCtD
Tinidazole—Stomatitis—Docetaxel—skin cancer	0.000573	0.00221	CcSEcCtD
Tinidazole—Leukopenia—Fluorouracil—skin cancer	0.00057	0.0022	CcSEcCtD
Tinidazole—Confusional state—Temozolomide—skin cancer	0.000569	0.00219	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000568	0.00219	CcSEcCtD
Tinidazole—Nausea—Imiquimod—skin cancer	0.000559	0.00216	CcSEcCtD
Tinidazole—Nervous system disorder—Temozolomide—skin cancer	0.000553	0.00213	CcSEcCtD
Tinidazole—Thrombocytopenia—Temozolomide—skin cancer	0.000552	0.00213	CcSEcCtD
Tinidazole—Convulsion—Fluorouracil—skin cancer	0.000552	0.00213	CcSEcCtD
Tinidazole—Feeling abnormal—Bleomycin—skin cancer	0.000551	0.00213	CcSEcCtD
Tinidazole—Skin disorder—Temozolomide—skin cancer	0.000548	0.00211	CcSEcCtD
Tinidazole—Hyperhidrosis—Temozolomide—skin cancer	0.000545	0.0021	CcSEcCtD
Tinidazole—Myalgia—Fluorouracil—skin cancer	0.000542	0.00209	CcSEcCtD
Tinidazole—Decreased appetite—Dactinomycin—skin cancer	0.000542	0.00209	CcSEcCtD
Tinidazole—Fatigue—Dactinomycin—skin cancer	0.000538	0.00207	CcSEcCtD
Tinidazole—Anorexia—Temozolomide—skin cancer	0.000538	0.00207	CcSEcCtD
Tinidazole—Discomfort—Fluorouracil—skin cancer	0.000536	0.00207	CcSEcCtD
Tinidazole—Urticaria—Bleomycin—skin cancer	0.000531	0.00205	CcSEcCtD
Tinidazole—Body temperature increased—Bleomycin—skin cancer	0.000529	0.00204	CcSEcCtD
Tinidazole—Hypoaesthesia—Docetaxel—skin cancer	0.000525	0.00203	CcSEcCtD
Tinidazole—Confusional state—Fluorouracil—skin cancer	0.000524	0.00202	CcSEcCtD
Tinidazole—Pharyngitis—Docetaxel—skin cancer	0.000524	0.00202	CcSEcCtD
Tinidazole—Urinary tract disorder—Docetaxel—skin cancer	0.000521	0.00201	CcSEcCtD
Tinidazole—Urethral disorder—Docetaxel—skin cancer	0.000518	0.002	CcSEcCtD
Tinidazole—Feeling abnormal—Dactinomycin—skin cancer	0.000514	0.00198	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000514	0.00198	CcSEcCtD
Tinidazole—Insomnia—Temozolomide—skin cancer	0.00051	0.00197	CcSEcCtD
Tinidazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.00051	0.00197	CcSEcCtD
Tinidazole—Nervous system disorder—Fluorouracil—skin cancer	0.00051	0.00197	CcSEcCtD
Tinidazole—Thrombocytopenia—Fluorouracil—skin cancer	0.000509	0.00196	CcSEcCtD
Tinidazole—Paraesthesia—Temozolomide—skin cancer	0.000507	0.00195	CcSEcCtD
Tinidazole—Dyspnoea—Temozolomide—skin cancer	0.000503	0.00194	CcSEcCtD
Tinidazole—Somnolence—Temozolomide—skin cancer	0.000502	0.00193	CcSEcCtD
Tinidazole—Erythema multiforme—Docetaxel—skin cancer	0.000499	0.00193	CcSEcCtD
Tinidazole—Dyspepsia—Temozolomide—skin cancer	0.000497	0.00191	CcSEcCtD
Tinidazole—Anorexia—Fluorouracil—skin cancer	0.000495	0.00191	CcSEcCtD
Tinidazole—Abdominal pain—Dactinomycin—skin cancer	0.000493	0.0019	CcSEcCtD
Tinidazole—Body temperature increased—Dactinomycin—skin cancer	0.000493	0.0019	CcSEcCtD
Tinidazole—Hypersensitivity—Bleomycin—skin cancer	0.000493	0.0019	CcSEcCtD
Tinidazole—Decreased appetite—Temozolomide—skin cancer	0.00049	0.00189	CcSEcCtD
Tinidazole—Flushing—Docetaxel—skin cancer	0.00049	0.00189	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Temozolomide—skin cancer	0.000487	0.00188	CcSEcCtD
Tinidazole—Fatigue—Temozolomide—skin cancer	0.000486	0.00188	CcSEcCtD
Tinidazole—Constipation—Temozolomide—skin cancer	0.000482	0.00186	CcSEcCtD
Tinidazole—Asthenia—Bleomycin—skin cancer	0.00048	0.00185	CcSEcCtD
Tinidazole—Angiopathy—Docetaxel—skin cancer	0.000479	0.00185	CcSEcCtD
Tinidazole—Immune system disorder—Docetaxel—skin cancer	0.000477	0.00184	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000474	0.00183	CcSEcCtD
Tinidazole—Pruritus—Bleomycin—skin cancer	0.000473	0.00182	CcSEcCtD
Tinidazole—Insomnia—Fluorouracil—skin cancer	0.00047	0.00181	CcSEcCtD
Tinidazole—Paraesthesia—Fluorouracil—skin cancer	0.000467	0.0018	CcSEcCtD
Tinidazole—Feeling abnormal—Temozolomide—skin cancer	0.000465	0.00179	CcSEcCtD
Tinidazole—Dyspnoea—Fluorouracil—skin cancer	0.000463	0.00179	CcSEcCtD
Tinidazole—Somnolence—Fluorouracil—skin cancer	0.000462	0.00178	CcSEcCtD
Tinidazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000461	0.00178	CcSEcCtD
Tinidazole—Malnutrition—Docetaxel—skin cancer	0.00046	0.00177	CcSEcCtD
Tinidazole—Hypersensitivity—Dactinomycin—skin cancer	0.00046	0.00177	CcSEcCtD
Tinidazole—Dyspepsia—Fluorouracil—skin cancer	0.000458	0.00176	CcSEcCtD
Tinidazole—Decreased appetite—Fluorouracil—skin cancer	0.000452	0.00174	CcSEcCtD
Tinidazole—Dysgeusia—Docetaxel—skin cancer	0.00045	0.00174	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000449	0.00173	CcSEcCtD
Tinidazole—Urticaria—Temozolomide—skin cancer	0.000448	0.00173	CcSEcCtD
Tinidazole—Asthenia—Dactinomycin—skin cancer	0.000447	0.00173	CcSEcCtD
Tinidazole—Body temperature increased—Temozolomide—skin cancer	0.000446	0.00172	CcSEcCtD
Tinidazole—Abdominal pain—Temozolomide—skin cancer	0.000446	0.00172	CcSEcCtD
Tinidazole—Muscle spasms—Docetaxel—skin cancer	0.000442	0.0017	CcSEcCtD
Tinidazole—Feeling abnormal—Fluorouracil—skin cancer	0.000428	0.00165	CcSEcCtD
Tinidazole—Diarrhoea—Dactinomycin—skin cancer	0.000427	0.00165	CcSEcCtD
Tinidazole—Vomiting—Bleomycin—skin cancer	0.000425	0.00164	CcSEcCtD
Tinidazole—Rash—Bleomycin—skin cancer	0.000422	0.00163	CcSEcCtD
Tinidazole—Dermatitis—Bleomycin—skin cancer	0.000421	0.00162	CcSEcCtD
Tinidazole—Hypersensitivity—Temozolomide—skin cancer	0.000416	0.0016	CcSEcCtD
Tinidazole—Urticaria—Fluorouracil—skin cancer	0.000413	0.00159	CcSEcCtD
Tinidazole—Leukopenia—Docetaxel—skin cancer	0.000411	0.00159	CcSEcCtD
Tinidazole—Body temperature increased—Fluorouracil—skin cancer	0.000411	0.00158	CcSEcCtD
Tinidazole—Palpitations—Docetaxel—skin cancer	0.000406	0.00157	CcSEcCtD
Tinidazole—Asthenia—Temozolomide—skin cancer	0.000405	0.00156	CcSEcCtD
Tinidazole—Pruritus—Temozolomide—skin cancer	0.000399	0.00154	CcSEcCtD
Tinidazole—Convulsion—Docetaxel—skin cancer	0.000398	0.00154	CcSEcCtD
Tinidazole—Nausea—Bleomycin—skin cancer	0.000397	0.00153	CcSEcCtD
Tinidazole—Vomiting—Dactinomycin—skin cancer	0.000397	0.00153	CcSEcCtD
Tinidazole—Rash—Dactinomycin—skin cancer	0.000393	0.00152	CcSEcCtD
Tinidazole—Arthralgia—Docetaxel—skin cancer	0.000391	0.00151	CcSEcCtD
Tinidazole—Myalgia—Docetaxel—skin cancer	0.000391	0.00151	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000389	0.0015	CcSEcCtD
Tinidazole—Diarrhoea—Temozolomide—skin cancer	0.000386	0.00149	CcSEcCtD
Tinidazole—Hypersensitivity—Fluorouracil—skin cancer	0.000383	0.00148	CcSEcCtD
Tinidazole—Confusional state—Docetaxel—skin cancer	0.000378	0.00146	CcSEcCtD
Tinidazole—Dizziness—Temozolomide—skin cancer	0.000373	0.00144	CcSEcCtD
Tinidazole—Nausea—Dactinomycin—skin cancer	0.00037	0.00143	CcSEcCtD
Tinidazole—Nervous system disorder—Docetaxel—skin cancer	0.000368	0.00142	CcSEcCtD
Tinidazole—Pruritus—Fluorouracil—skin cancer	0.000368	0.00142	CcSEcCtD
Tinidazole—Thrombocytopenia—Docetaxel—skin cancer	0.000367	0.00142	CcSEcCtD
Tinidazole—Skin disorder—Docetaxel—skin cancer	0.000364	0.00141	CcSEcCtD
Tinidazole—Vomiting—Temozolomide—skin cancer	0.000359	0.00138	CcSEcCtD
Tinidazole—Anorexia—Docetaxel—skin cancer	0.000358	0.00138	CcSEcCtD
Tinidazole—Rash—Temozolomide—skin cancer	0.000356	0.00137	CcSEcCtD
Tinidazole—Diarrhoea—Fluorouracil—skin cancer	0.000356	0.00137	CcSEcCtD
Tinidazole—Dermatitis—Temozolomide—skin cancer	0.000355	0.00137	CcSEcCtD
Tinidazole—Headache—Temozolomide—skin cancer	0.000353	0.00136	CcSEcCtD
Tinidazole—Dizziness—Fluorouracil—skin cancer	0.000344	0.00133	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000342	0.00132	CcSEcCtD
Tinidazole—Insomnia—Docetaxel—skin cancer	0.000339	0.00131	CcSEcCtD
Tinidazole—Paraesthesia—Docetaxel—skin cancer	0.000337	0.0013	CcSEcCtD
Tinidazole—Nausea—Temozolomide—skin cancer	0.000335	0.00129	CcSEcCtD
Tinidazole—Dyspnoea—Docetaxel—skin cancer	0.000334	0.00129	CcSEcCtD
Tinidazole—Somnolence—Docetaxel—skin cancer	0.000334	0.00129	CcSEcCtD
Tinidazole—Vomiting—Fluorouracil—skin cancer	0.00033	0.00127	CcSEcCtD
Tinidazole—Dyspepsia—Docetaxel—skin cancer	0.00033	0.00127	CcSEcCtD
Tinidazole—Rash—Fluorouracil—skin cancer	0.000328	0.00126	CcSEcCtD
Tinidazole—Dermatitis—Fluorouracil—skin cancer	0.000327	0.00126	CcSEcCtD
Tinidazole—Decreased appetite—Docetaxel—skin cancer	0.000326	0.00126	CcSEcCtD
Tinidazole—Headache—Fluorouracil—skin cancer	0.000326	0.00126	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Docetaxel—skin cancer	0.000324	0.00125	CcSEcCtD
Tinidazole—Fatigue—Docetaxel—skin cancer	0.000323	0.00125	CcSEcCtD
Tinidazole—Constipation—Docetaxel—skin cancer	0.000321	0.00124	CcSEcCtD
Tinidazole—Feeling abnormal—Docetaxel—skin cancer	0.000309	0.00119	CcSEcCtD
Tinidazole—Nausea—Fluorouracil—skin cancer	0.000309	0.00119	CcSEcCtD
Tinidazole—Gastrointestinal pain—Docetaxel—skin cancer	0.000307	0.00118	CcSEcCtD
Tinidazole—Abdominal pain—Docetaxel—skin cancer	0.000297	0.00114	CcSEcCtD
Tinidazole—Body temperature increased—Docetaxel—skin cancer	0.000297	0.00114	CcSEcCtD
Tinidazole—Hypersensitivity—Docetaxel—skin cancer	0.000276	0.00107	CcSEcCtD
Tinidazole—Asthenia—Docetaxel—skin cancer	0.000269	0.00104	CcSEcCtD
Tinidazole—Pruritus—Docetaxel—skin cancer	0.000265	0.00102	CcSEcCtD
Tinidazole—Diarrhoea—Docetaxel—skin cancer	0.000257	0.00099	CcSEcCtD
Tinidazole—Dizziness—Docetaxel—skin cancer	0.000248	0.000957	CcSEcCtD
Tinidazole—Vomiting—Docetaxel—skin cancer	0.000239	0.00092	CcSEcCtD
Tinidazole—Rash—Docetaxel—skin cancer	0.000237	0.000912	CcSEcCtD
Tinidazole—Dermatitis—Docetaxel—skin cancer	0.000236	0.000911	CcSEcCtD
Tinidazole—Headache—Docetaxel—skin cancer	0.000235	0.000906	CcSEcCtD
Tinidazole—Nausea—Docetaxel—skin cancer	0.000223	0.000859	CcSEcCtD
